Latest News about GSK
Recent news which mentions GSK
Johnson & Johnson Stock: Bull vs. Bear
December 27, 2021
From Motley Fool
From Benzinga
My 3 Favorite Under-the-Radar Healthcare Stocks for 2022
December 21, 2021
From Motley Fool
Long-Acting HIV Treatment Backed By GSK, Pfizer Scores FDA Approval As Preventative Option
December 21, 2021
From Benzinga
7 Stocks to Buy if Covid-19 Becomes Endemic
December 20, 2021
From InvestorPlace
From Benzinga
2 Cheap Stocks With 10X Potential to Buy in 2022
December 16, 2021
From Motley Fool
Why Vir Biotechnology Stock Surged Today
December 15, 2021
From Motley Fool
Drug makers move forward with new COVID-19 booster candidates amid omicron’s spread and mass booster campaigns
December 15, 2021
From MarketWatch
Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back
December 15, 2021
From Benzinga
Why Are Vir Biotech Shares Gaining Today?
December 15, 2021
From Benzinga
Omicron variant remains a ‘very high’ risk as it spreads fast and shows resistance to vaccines, but WHO says more data needed to know if it’s more lethal
December 15, 2021
From MarketWatch
The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO
December 15, 2021
From Benzinga
From MarketWatch
3 Top IPO Stocks to Put on Your Watchlist
December 13, 2021
From Motley Fool
From Motley Fool
From MarketWatch
Why Amazon Stock Was Higher Today
December 07, 2021
From Motley Fool
Cramer Gives His Opinion On GlaxoSmithKline, Asana And More
December 07, 2021
From Benzinga
Vir, GSK’s COVID-19 antibody treatment works against omicron in a lab study, and WHO no longer recommends convalescent plasma
December 07, 2021
From MarketWatch
Investors Do A Little Holiday Value Shopping On Monday
December 07, 2021
From Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
Medicago, GSK's Plant-Based COVID-19 Vaccine Candidate Hits 75% Efficacy Against Delta Strain
December 07, 2021
Tickers
GSK
From Benzinga
From Benzinga
From MarketWatch
3 Must-Own Dividend Stocks in This Chaotic Market
December 06, 2021
From Motley Fool
Here's Why Biotech Stocks Adaptimmune Therapeutics, Agenus, and Ocugen All Crashed in November
December 04, 2021
From Motley Fool
Why Jim Cramer Likes Enbridge, Vir Biotechnology And More
December 03, 2021
From Benzinga
AUPH Stock: The Novartis Takeover Talk That Has Aurinia Pharma Shares Taking Off Today
December 02, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.